Cancer Biological Therapy Market Trend, Share, Growth, Size Analysis and Forecast 2030
Cancer Biological Therapy Market By Application (Diagnostic Laboratories, Hospitals, Pharmaceutical & Biotechnology Companies, and Research & Academic Laboratories), By Product (Vaccines {Therapeutic Vaccines And Preventive Vaccines}, Monoclonal Antibodies { Conjugated Monoclonal Antibodies, Naked Monoclonal Antibodies, And Bispecific Monoclonal Antibodies}, Blood Cell Growth Factors {Filgrastim And Lenograstim}, Cancer Growth Blockers { Proteasome Inhibitors, Tyrosine Kinase Inhibitors, And MTOR Inhibitors}, and Cytokine { Interleukin And Interferon}), and By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 - 2030
Category: Biotechnology Report Format : PDF
Pages: 225 Report Code: ZMR-3862
Published Date: Aug-2023 Status : Published
| Market Size in 2022 | Market Forecast in 2030 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 112 Billion | USD 220 Billion | 7.2% | 2022 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Cancer Biological Therapy Market, (2023 - 2030) (USD Billion)
- 2.2 Global Cancer Biological Therapy Market : snapshot
- Chapter 3. Global Cancer Biological Therapy Market - Industry Analysis
- 3.1 Cancer Biological Therapy Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 The surge in cancer occurrence to boost the global market demand across the globe over 2023-2030
- 3.3 Market Restraints
- 3.3.1. Side effects of treatment in patients can prove detrimental to the global industry expansion
- 3.4 Market Opportunities
- 3.4.1. Rise in fundraising and investments for developing innovative cancer treatment modes to open new growth avenues for the global market
- 3.5 Market Challenges
- 3.5.1. Huge treatment costs and low availability of professionals can put up a huge challenge in the growth path of the industry across the globe
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Application
- 3.7.2 Market attractiveness analysis By Product Type
- Chapter 4. Global Cancer Biological Therapy Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Cancer Biological Therapy Market: company market share, 2022
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Cancer Biological Therapy Market - Application Analysis
- 5.1 Global Cancer Biological Therapy Market overview: By Application
- 5.1.1 Global Cancer Biological Therapy Market share, By Application , 2022 and 2030
- 5.2 Diagnostic Laboratories
- 5.2.1 Global Cancer Biological Therapy Market by Diagnostic Laboratories, 2023 - 2030 (USD Billion)
- 5.3 Hospitals
- 5.3.1 Global Cancer Biological Therapy Market by Hospitals, 2023 - 2030 (USD Billion)
- 5.4 Pharmaceutical & Biotechnology Companies
- 5.4.1 Global Cancer Biological Therapy Market by Pharmaceutical & Biotechnology Companies, 2023 - 2030 (USD Billion)
- 5.5 Research & Academic Laboratories
- 5.5.1 Global Cancer Biological Therapy Market by Research & Academic Laboratories, 2023 - 2030 (USD Billion)
- 5.1 Global Cancer Biological Therapy Market overview: By Application
- Chapter 6. Global Cancer Biological Therapy Market - Product Type Analysis
- 6.1 Global Cancer Biological Therapy Market overview: By Product Type
- 6.1.1 Global Cancer Biological Therapy Market share, By Product Type, 2022 and 2030
- 6.2 Monoclonal Antibodies
- 6.2.1 Global Cancer Biological Therapy Market by Monoclonal Antibodies, 2023 - 2030 (USD Billion)
- 6.3 Vaccines
- 6.3.1 Global Cancer Biological Therapy Market by Vaccines, 2023 - 2030 (USD Billion)
- 6.4 Cancer Growth Blockers
- 6.4.1 Global Cancer Biological Therapy Market by Cancer Growth Blockers, 2023 - 2030 (USD Billion)
- 6.5 Blood Cell Growth Factors
- 6.5.1 Global Cancer Biological Therapy Market by Blood Cell Growth Factors, 2023 - 2030 (USD Billion)
- 6.6 Cytokine
- 6.6.1 Global Cancer Biological Therapy Market by Cytokine, 2023 - 2030 (USD Billion)
- 6.1 Global Cancer Biological Therapy Market overview: By Product Type
- Chapter 7. Cancer Biological Therapy Market - Regional Analysis
- 7.1 Global Cancer Biological Therapy Market Regional Overview
- 7.2 Global Cancer Biological Therapy Market Share, by Region, 2022 & 2030 (USD Billion)
- 7.3. North America
- 7.3.1 North America Cancer Biological Therapy Market, 2023 - 2030 (USD Billion)
- 7.3.1.1 North America Cancer Biological Therapy Market, by Country, 2023 - 2030 (USD Billion)
- 7.3.1 North America Cancer Biological Therapy Market, 2023 - 2030 (USD Billion)
- 7.4 North America Cancer Biological Therapy Market, by Application , 2023 - 2030
- 7.4.1 North America Cancer Biological Therapy Market, by Application , 2023 - 2030 (USD Billion)
- 7.5 North America Cancer Biological Therapy Market, by Product Type, 2023 - 2030
- 7.5.1 North America Cancer Biological Therapy Market, by Product Type, 2023 - 2030 (USD Billion)
- 7.4. Europe
- 7.4.2 Europe Cancer Biological Therapy Market, 2023 - 2030 (USD Billion)
- 7.4.2.1 Europe Cancer Biological Therapy Market, by Country, 2023 - 2030 (USD Billion)
- 7.4.2 Europe Cancer Biological Therapy Market, 2023 - 2030 (USD Billion)
- 7.4 Europe Cancer Biological Therapy Market, by Application , 2023 - 2030
- 7.4.1 Europe Cancer Biological Therapy Market, by Application , 2023 - 2030 (USD Billion)
- 7.5 Europe Cancer Biological Therapy Market, by Product Type, 2023 - 2030
- 7.5.1 Europe Cancer Biological Therapy Market, by Product Type, 2023 - 2030 (USD Billion)
- 7.5. Asia Pacific
- 7.5.3 Asia Pacific Cancer Biological Therapy Market, 2023 - 2030 (USD Billion)
- 7.5.3.1 Asia Pacific Cancer Biological Therapy Market, by Country, 2023 - 2030 (USD Billion)
- 7.5.3 Asia Pacific Cancer Biological Therapy Market, 2023 - 2030 (USD Billion)
- 7.4 Asia Pacific Cancer Biological Therapy Market, by Application , 2023 - 2030
- 7.4.1 Asia Pacific Cancer Biological Therapy Market, by Application , 2023 - 2030 (USD Billion)
- 7.5 Asia Pacific Cancer Biological Therapy Market, by Product Type, 2023 - 2030
- 7.5.1 Asia Pacific Cancer Biological Therapy Market, by Product Type, 2023 - 2030 (USD Billion)
- 7.6. Latin America
- 7.6.4 Latin America Cancer Biological Therapy Market, 2023 - 2030 (USD Billion)
- 7.6.4.1 Latin America Cancer Biological Therapy Market, by Country, 2023 - 2030 (USD Billion)
- 7.6.4 Latin America Cancer Biological Therapy Market, 2023 - 2030 (USD Billion)
- 7.4 Latin America Cancer Biological Therapy Market, by Application , 2023 - 2030
- 7.4.1 Latin America Cancer Biological Therapy Market, by Application , 2023 - 2030 (USD Billion)
- 7.5 Latin America Cancer Biological Therapy Market, by Product Type, 2023 - 2030
- 7.5.1 Latin America Cancer Biological Therapy Market, by Product Type, 2023 - 2030 (USD Billion)
- 7.7. The Middle-East and Africa
- 7.7.5 The Middle-East and Africa Cancer Biological Therapy Market, 2023 - 2030 (USD Billion)
- 7.7.5.1 The Middle-East and Africa Cancer Biological Therapy Market, by Country, 2023 - 2030 (USD Billion)
- 7.7.5 The Middle-East and Africa Cancer Biological Therapy Market, 2023 - 2030 (USD Billion)
- 7.4 The Middle-East and Africa Cancer Biological Therapy Market, by Application , 2023 - 2030
- 7.4.1 The Middle-East and Africa Cancer Biological Therapy Market, by Application , 2023 - 2030 (USD Billion)
- 7.5 The Middle-East and Africa Cancer Biological Therapy Market, by Product Type, 2023 - 2030
- 7.5.1 The Middle-East and Africa Cancer Biological Therapy Market, by Product Type, 2023 - 2030 (USD Billion)
- Chapter 8. Company Profiles
- 8.1 Bristol-Myers Squibb
- 8.1.1 Overview
- 8.1.2 Financials
- 8.1.3 Product Portfolio
- 8.1.4 Business Strategy
- 8.1.5 Recent Developments
- 8.2 Spectrum Pharmaceuticals
- 8.2.1 Overview
- 8.2.2 Financials
- 8.2.3 Product Portfolio
- 8.2.4 Business Strategy
- 8.2.5 Recent Developments
- 8.3 Amgen
- 8.3.1 Overview
- 8.3.2 Financials
- 8.3.3 Product Portfolio
- 8.3.4 Business Strategy
- 8.3.5 Recent Developments
- 8.4 F. Hoffmann-La Roche
- 8.4.1 Overview
- 8.4.2 Financials
- 8.4.3 Product Portfolio
- 8.4.4 Business Strategy
- 8.4.5 Recent Developments
- 8.5 AbbVie
- 8.5.1 Overview
- 8.5.2 Financials
- 8.5.3 Product Portfolio
- 8.5.4 Business Strategy
- 8.5.5 Recent Developments
- 8.6 AstraZeneca
- 8.6.1 Overview
- 8.6.2 Financials
- 8.6.3 Product Portfolio
- 8.6.4 Business Strategy
- 8.6.5 Recent Developments
- 8.7 Novartis AG
- 8.7.1 Overview
- 8.7.2 Financials
- 8.7.3 Product Portfolio
- 8.7.4 Business Strategy
- 8.7.5 Recent Developments
- 8.8 Astellas
- 8.8.1 Overview
- 8.8.2 Financials
- 8.8.3 Product Portfolio
- 8.8.4 Business Strategy
- 8.8.5 Recent Developments
- 8.9 Pfizer
- 8.9.1 Overview
- 8.9.2 Financials
- 8.9.3 Product Portfolio
- 8.9.4 Business Strategy
- 8.9.5 Recent Developments
- 8.10 Celgene Corporation
- 8.10.1 Overview
- 8.10.2 Financials
- 8.10.3 Product Portfolio
- 8.10.4 Business Strategy
- 8.10.5 Recent Developments
- 8.11 Sanofi
- 8.11.1 Overview
- 8.11.2 Financials
- 8.11.3 Product Portfolio
- 8.11.4 Business Strategy
- 8.11.5 Recent Developments
- 8.12 Takeda Pharmaceuticals
- 8.12.1 Overview
- 8.12.2 Financials
- 8.12.3 Product Portfolio
- 8.12.4 Business Strategy
- 8.12.5 Recent Developments
- 8.13 Bayer
- 8.13.1 Overview
- 8.13.2 Financials
- 8.13.3 Product Portfolio
- 8.13.4 Business Strategy
- 8.13.5 Recent Developments
- 8.14 ELI Lilly & Company
- 8.14.1 Overview
- 8.14.2 Financials
- 8.14.3 Product Portfolio
- 8.14.4 Business Strategy
- 8.14.5 Recent Developments
- 8.15 Eisai
- 8.15.1 Overview
- 8.15.2 Financials
- 8.15.3 Product Portfolio
- 8.15.4 Business Strategy
- 8.15.5 Recent Developments
- 8.16 GlaxoSmithKline
- 8.16.1 Overview
- 8.16.2 Financials
- 8.16.3 Product Portfolio
- 8.16.4 Business Strategy
- 8.16.5 Recent Developments
- 8.17 Merck
- 8.17.1 Overview
- 8.17.2 Financials
- 8.17.3 Product Portfolio
- 8.17.4 Business Strategy
- 8.17.5 Recent Developments
- 8.18 Incyte
- 8.18.1 Overview
- 8.18.2 Financials
- 8.18.3 Product Portfolio
- 8.18.4 Business Strategy
- 8.18.5 Recent Developments
- 8.19 Otsuka
- 8.19.1 Overview
- 8.19.2 Financials
- 8.19.3 Product Portfolio
- 8.19.4 Business Strategy
- 8.19.5 Recent Developments
- 8.20 and Seattle Genetics.
- 8.20.1 Overview
- 8.20.2 Financials
- 8.20.3 Product Portfolio
- 8.20.4 Business Strategy
- 8.20.5 Recent Developments
- 8.1 Bristol-Myers Squibb
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Cancer Biological Therapy Market, 2023 - 2030 (USD Billion)
- 4. Porter’s Five Forces Analysis
- 5. Global Cancer Biological Therapy Market attractiveness, By Application
- 6. Global Cancer Biological Therapy Market attractiveness, By Product Type
- 7. Global Cancer Biological Therapy Market share by Application , 2023 and 2030 (USD Billion)
- 8. Global Cancer Biological Therapy Market by Diagnostic Laboratories, 2023 - 2030 (USD Billion)
- 9. Global Cancer Biological Therapy Market by Hospitals, 2023 - 2030 (USD Billion)
- 10. Global Cancer Biological Therapy Market by Pharmaceutical & Biotechnology Companies, 2023 - 2030 (USD Billion)
- 11. Global Cancer Biological Therapy Market by Research & Academic Laboratories, 2023 - 2030 (USD Billion)
- 12. Global Cancer Biological Therapy Market share by Product Type, 2023 and 2030 (USD Billion)
- 13. Global Cancer Biological Therapy Market by Monoclonal Antibodies, 2023 - 2030 (USD Billion)
- 14. Global Cancer Biological Therapy Market by Vaccines, 2023 - 2030 (USD Billion)
- 15. Global Cancer Biological Therapy Market by Cancer Growth Blockers, 2023 - 2030 (USD Billion)
- 16. Global Cancer Biological Therapy Market by Blood Cell Growth Factors, 2023 - 2030 (USD Billion)
- 17. Global Cancer Biological Therapy Market by Cytokine, 2023 - 2030 (USD Billion)
- 18. Global Cancer Biological Therapy Market share, by Region, 2023 and 2030
- 19. North America Cancer Biological Therapy Market, 2023 - 2030 (USD Billion)
- 20. Europe Cancer Biological Therapy Market, 2023 - 2030 (USD Billion)
- 21. Asia Pacific Cancer Biological Therapy Market, 2023 - 2030 (USD Billion)
- 22. Latin America Cancer Biological Therapy Market, 2023 - 2030 (USD Billion)
- 23. The Middle-East and Africa Cancer Biological Therapy Market, 2023 - 2030 (USD Billion)
Table Of Tables
- 1. Global Cancer Biological Therapy Market: Snapshot
- 2. Drivers of the Cancer Biological Therapy Market: impact analysis
- 3. North America Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
- 4. North America Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 5. U.S. Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
- 6. U.S. Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 7. Canada Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
- 8. Canada Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 9. Europe Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
- 10. Europe Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 11. Germany Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
- 12. Germany Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 13. France Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
- 14. France Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 15. U.K. Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
- 16. U.K. Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 17. Italy Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
- 18. Italy Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 19. Spain Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
- 20. Spain Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 21. Rest of Europe Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
- 22. Rest of Europe Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 23. Asia Pacific Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
- 24. Asia Pacific Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 25. China Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
- 26. China Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 27. Japan Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
- 28. Japan Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 29. India Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
- 30. India Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 31. South Korea Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
- 32. South Korea Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 33. South-East Asia Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
- 34. South-East Asia Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 35. Rest of Asia Pacific Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
- 36. Rest of Asia Pacific Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 37. Latin America Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
- 38. Latin America Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 39. Brazil Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
- 40. Brazil Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 41. Mexico Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
- 42. Mexico Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 43. Rest of Latin America Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
- 44. Rest of Latin America Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 45. The Middle-East and Africa Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
- 46. The Middle-East and Africa Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 47. GCC Countries Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
- 48. GCC Countries Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 49. South Africa Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
- 50. South Africa Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 51. Rest of Middle-East Africa Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
- 52. Rest of Middle-East Africa Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
Methodology
FrequentlyAsked Questions
Biological therapy or biotherapy is a new cancer treatment method. It makes use of biological response modifiers as well as biologicals for treating cancer.
The global cancer biological therapy market growth is owing to the launching of new cancer biologics & drug discovery platforms for treating cancer.
According to a study, the global cancer biological therapy industry size was $112 billion in 2022 and is projected to reach $220 billion by the end of 2030.
The global cancer biological therapy market is anticipated to record a CAGR of nearly 7.2% from 2023 to 2030.
The Europe cancer biological therapy industry is set to register the highest CAGR over the forecasting timeline owing to the rise in awareness about oncology among the people along with growing demand for advanced cancer therapies in the continent. Apart from this, the presence of key players in the countries of Europe will majorly contribute to the industry expansion in the continent in the years to come.
The global cancer biological therapy market is led by players such as Bristol-Myers Squibb, Spectrum Pharmaceuticals, Amgen, F. Hoffmann-La Roche, AbbVie, AstraZeneca, Novartis AG, Astellas, Pfizer, Celgene Corporation, Sanofi, Takeda Pharmaceuticals, Bayer, ELI Lilly & Company, Eisai, GlaxoSmithKline, Merck, Incyte, Otsuka, and Seattle Genetics.
The cancer biological therapy market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTEL analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five force analysis, and value chain analysis.
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed